These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current status and future directions of botulinum neurotoxins for targeting pain processing. Pellett S; Yaksh TL; Ramachandran R Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371 [TBL] [Abstract][Full Text] [Related]
23. [Inhibition of neurotransmitter release by tetanus and botulinum neurotoxins]. Mochida S Seikagaku; 1994 Mar; 66(3):254-9. PubMed ID: 7909831 [No Abstract] [Full Text] [Related]
24. Targeted secretion inhibitors-innovative protein therapeutics. Keith F; John C Toxins (Basel); 2010 Dec; 2(12):2795-815. PubMed ID: 22069575 [TBL] [Abstract][Full Text] [Related]
25. Restoration of transmitter release in botulinum-poisoned skeletal muscle. Lundh H; Cull-Candy SG; Leander S; Thesleff S Brain Res; 1976 Jun; 110(1):194-8. PubMed ID: 6127 [No Abstract] [Full Text] [Related]
26. The interaction between aminoquinolines and presynaptically acting neurotoxins. Simpson LL J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072 [TBL] [Abstract][Full Text] [Related]
27. Clostridial neurotoxins in the age of molecular medicine. Coffield JA; Considine RV; Simpson LL Trends Microbiol; 1994 Mar; 2(3):67-9; discussion 69-72. PubMed ID: 7908844 [No Abstract] [Full Text] [Related]
28. Engineering of Botulinum Neurotoxins for Biomedical Applications. Webb RP Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29882791 [TBL] [Abstract][Full Text] [Related]
29. Botulinum neurotoxin: the ugly duckling. Koussoulakos S Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125 [TBL] [Abstract][Full Text] [Related]
30. Calcium and transmitter release. Cohen I; Van der Kloot W Int Rev Neurobiol; 1985; 27():299-336. PubMed ID: 2867980 [No Abstract] [Full Text] [Related]
33. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins]. Poulain B Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455 [TBL] [Abstract][Full Text] [Related]
34. Different mechanisms of inhibition of nerve terminals by botulinum and snake presynaptic neurotoxins. Montecucco C; Rossetto O; Caccin P; Rigoni M; Carli L; Morbiato L; Muraro L; Paoli M Toxicon; 2009 Oct; 54(5):561-4. PubMed ID: 19111566 [TBL] [Abstract][Full Text] [Related]
35. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip. Tehran DA; Pirazzini M Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Wheeler A; Smith HS Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179 [TBL] [Abstract][Full Text] [Related]
37. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain. Poulain B; Tauc L; Maisey EA; Wadsworth JD; Mohan PM; Dolly JO Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4090-4. PubMed ID: 2897693 [TBL] [Abstract][Full Text] [Related]
38. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins. Simpson LL J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038 [TBL] [Abstract][Full Text] [Related]
39. [Action of toxin II isolated from the tentacles of sea anemones on the neuromuscular transmission on normal and botulin toxin inhibited frogs]. Tazieff-Depierre F; Métézeau P; Wunderer G C R Acad Hebd Seances Acad Sci D; 1978 Feb; 286(8):655-8. PubMed ID: 27319 [TBL] [Abstract][Full Text] [Related]
40. Effects of botulinum A toxin on presynaptic modulation of evoked transmitter release. Nakov R; Habermann E; Hertting G; Wurster S; Allgaier C Eur J Pharmacol; 1989 May; 164(1):45-53. PubMed ID: 2568939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]